SueWallSt Reminds Shareholders of a Lead Plaintiff Deadline of August 3, 2026 in Badger Meter, Inc. Lawsuit – BMI

PR Newswire

Badger Meter Promised Investors “High Single-Digit” Growth Driven by “Robust Demand” — Then Delivered a 9% Revenue Decline and $36.75 Per Share in Losses When the Truth Emerged

NEW YORK, June 4, 2026 /PRNewswire/ — SueWallSt highlights the contrast between Badger Meter, Inc.’s (NYSE: BMI) promises to shareholders and the results that ultimately materialized. Find out if you can recover your Badger Meter investment losses or contact Joseph E. Levi, Esq. at [email protected] or (888) SueWallSt.

SueWallSt.com

BMI shares collapsed more than 24%, losing $36.75 per share on April 17, 2026, after the company disclosed total sales fell 9% year-over-year and utility water revenue dropped 10%. The lead plaintiff deadline is August 3, 2026.

The Promise

Throughout 2024 and into early 2025, Badger Meter’s leadership painted a picture of durable, accelerating growth for investors. The company projected “high single-digit average top line growth” supported by what it described as “ongoing favorable industry fundamentals” and “secular growth drivers.” Management characterized demand as “robust” and told the market its order book and opportunity pipeline “continue to support” the growth outlook. On the 1Q 2025 earnings call, the company went further, directly rejecting the possibility that customers were pulling orders forward, asserting that 75% of revenue went to end users who “really, in many ways, cannot pull forward.”

The Reality

The company’s actual trajectory told a different story:

  • Promised: “High single-digit average top line growth” sustained by secular demand
  • Delivered: Total sales declined 9% year-over-year in 1Q 2026
  • Promised: Utility water revenue driven by “robust adoption rates” and “solid demand”
  • Delivered: Utility water sales fell 10% year-over-year in 1Q 2026
  • Promised: Operating margins expanding on “strong operating execution”
  • Delivered: Operating margin contracted from 22.2% to 17.4% in one year
  • Promised: EPS growth trajectory; 1Q 2025 delivered $1.30 diluted EPS
  • Delivered: Diluted EPS fell to $0.93 in 1Q 2026, a 28% decline
  • Promised: No evidence of customer order pull-forward; “pretty normal order environment”
  • Delivered: Management acknowledged $15 million to $20 million of revenue shortfall from “softer short-cycle municipal customer ordering”

What the Lawsuit Contends About the Gap

The securities action alleges that Badger Meter’s “record” results during the Class Period were not the product of genuine demand growth but were instead inflated by pulling forward customer orders, which depleted revenue from future periods. When backlog cushions thinned and short-cycle ordering weakened, the complaint asserts, the company could no longer mask the underlying deterioration. Management itself eventually conceded that the demand “variability” seen in 1Q 2026 “has always existed” during 2023-2025 but was “less visible” due to backlog levels and projects in flight.

“Companies that make specific promises to investors about future performance have an obligation to disclose known risks to those projections. The contrast between what Badger Meter communicated about its growth trajectory and what ultimately occurred raises serious questions for shareholders.” — Joseph E. Levi, Esq.

Speak with an attorney about recovering your BMI losses or call ☎(888) SueWallSt.

LEAD PLAINTIFF DEADLINE: August 3, 2026

About SueWallSt

SueWallSt is a nationally recognized shareholder rights firm. Over the past 20 years, the firm has secured hundreds of millions of dollars for aggrieved shareholders. Ranked in ISS Top 50 for seven consecutive years.

Frequently Asked Questions About the BMI Lawsuit

Q: What specific misstatements does the BMI lawsuit allege? A: The complaint alleges Badger Meter made materially false or misleading statements regarding the sustainability of its revenue growth, the strength of customer demand, and the absence of order pull-forward practices during the class period from April 18, 2024 through April 16, 2026. When the true state of demand was revealed, the stock price declined sharply.

Q: How much did BMI stock drop? A: Shares fell more than 24%, a decline of $36.75 per share, on April 17, 2026, after the company disclosed that total sales were 9% lower year-over-year and that short-cycle order rates were “weaker than anticipated.” Across three corrective disclosures, BMI lost over $95 per share.

Q: What do BMI investors need to do right now? A: Gather brokerage records including purchase dates, share quantities, and prices paid. Contact SueWallSt for a free, no-obligation evaluation at [email protected] or (888) SueWallSt. No immediate action is required to remain eligible as a class member.

Q: What if I already sold my BMI shares — can I still recover losses? A: Yes. Eligibility is based on when you purchased, not whether you still hold them. Investors who bought during the class period and sold at a loss may still participate.

Q: Do I need to go to court or give testimony? A: No. The overwhelming majority of class members never appear in court or give depositions. You submit a claim form to receive your portion of recovery.

Q: What does it cost me to participate? A: Nothing. Securities class actions are handled on a pure contingency basis. No upfront fees, no retainer, no out-of-pocket costs.

Q: Can I join a different law firm’s lawsuit instead? A: Multiple firms often file competing complaints. The court consolidates and appoints a single lead counsel. Contacting SueWallSt before August 3, 2026 ensures your losses are considered.

CONTACT:
SueWallSt
Joseph E. Levi, Esq.
Ed Korsinsky, Esq.
33 Whitehall Street, 27th Floor
New York, NY 10004
[email protected]
Tel: (888) SueWallSt
Fax: (212) 363-7171

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/suewallst-reminds-shareholders-of-a-lead-plaintiff-deadline-of-august-3-2026-in-badger-meter-inc-lawsuit—bmi-302791070.html

SOURCE SueWallSt.com

Kroger Serves up a Taste of Summer Nostalgia with New All-American Ice Cream Collection and Giveaway of 100,000 Free Pints

PR Newswire

From ballpark snacks to hometown diner desserts, Kroger Brand’s limited-time All-American Ice Cream Collection features three all-new flavors inspired by nostalgic Americana moments.

Kroger is also giving away 100,000 pints of free ice cream to celebrate the summer solstice.

CINCINNATI, June 4, 2026 /PRNewswire/ — The Kroger Co. (NYSE: KR) is bringing the iconic tastes of summer straight to the frozen aisle with Kroger Brand’s flavor-packed, limited-time All-American Ice Cream Collection. Now on shelves, the crave-worthy collection delivers the unmistakable tastes and traditions that define summer across the country – one creamy spoonful at a time. To celebrate, Kroger is bringing back its long-awaited free summer solstice pint offer on Friday, June 19 for the sweetest deal of the season.

From ballpark snacks to hometown diner desserts, Kroger Brand’s limited-time All-American Ice Cream Collection features three all-new flavors inspired by nostalgic Americana moments.

“Summer is all about bringing people together to create memories that last a lifetime, and we’re excited to capture that fun and nostalgia through our new All-American Ice Cream Collection,” said Ann Reed, Group Vice President of Our Brands at Kroger. “We’ve loved seeing customers come back year after year for their free pints and now, we’re going bigger than ever by giving away 100,000 pints.”

From making a road trip diner stop for cherry pie to sharing a banana split after a day in the sun, each flavor is inspired by the traditions and tastes that define an American summer:

  • Seventh Inning Swirl: Caramel popcorn flavored ice cream with praline peanuts and caramel swirls.
  • Sweet As Cherry Pie: Cherry pie flavored ice cream with tart cherry swirls and pie pieces.
  • Banana Split Social: Strawberry banana ice cream with pineapple chunks and chocolate swirls. 

The All-American Ice Cream Collection flavors are timeless, but the pints are limited, so be sure to stock up while supplies last.

Ahead of summer solstice on June 21, customers can grab a free pint to enjoy on the longest day of the year by visiting FreeKrogerIceCream.com to download their limited-time, single-use digital coupon, available exclusively on Friday, June 19, 2026, starting at 12pm EST, while supplies last. Customers can redeem the coupon to try one of the new All-American flavors or a classic Kroger Brand ice cream pint, such as Kroger® Cookies ‘N Cream Ice Cream or Kroger® Rocky Road Ice Cream. The coupon is redeemable at many Kroger Family of Stores locations from Friday, June 19 through Friday, July 3.*

Customers who aren’t able to snag this deal can still save $1 on any two pints of Kroger Brand ice cream for redemption through Friday, July 3.** Make the savings even sweeter with fuel savings all summer long, including 4X Fuel Points on frozen food from June 10-16 and 4X Fuel Points each Friday through June 26.***

For those craving a crunchy take on summer flavors, the new Kroger Brand Sizzlin’ Snack Trio Chip Collection brings the classic cheeseburger, chili cheese and buttered corn flavors of a cookout to life in potato chip form. From summer solstice parties to 4th of July backyard gatherings, Kroger has summer covered with flavor-packed favorites including Kroger® Red White & Blue Ice Cream Sandwiches, grill-ready go-tos like Kroger® 80/20 Ground Beef Patties and the new Private Selection® Pollo Asado Boneless Skinless Chicken Thighs, making it easy to round out any summer barbecue spread.

*Free ice cream pint promotion is valid in all U.S. states except CA, CO, LA, TN, NV and valid in all Kroger Family of Stores locations except QFC.  

**$1 off any purchase of two Kroger Brand ice cream pints promotion is valid in all Kroger Family Stores except QFC. 

***Customers earn 1 Fuel Point for every $1 spent on groceries, with points redeemable for discounts on fuel.

Media assets are available for download here.

About Kroger
At The Kroger Co. (NYSE: KR), we are dedicated to our Purpose: To Feed the Human Spirit™. We are, across our family of companies, more than 400,000 associates who serve over 11 million customers daily through an eCommerce experience and retail food stores under a variety of banner names, serving America through food inspiration and uplift, and creating #ZeroHungerZeroWaste communities. To learn more about us, visit our newsroom and investor relations site. 

 

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/kroger-serves-up-a-taste-of-summer-nostalgia-with-new-all-american-ice-cream-collection-and-giveaway-of-100-000-free-pints-302790688.html

SOURCE The Kroger Co.

Bank7 Corp. Declares Quarterly Cash Dividend on Common Stock

PR Newswire

OKLAHOMA CITY, June 4, 2026 /PRNewswire/ — Bank7 Corp. (NASDAQ: BSVN), the parent company of Oklahoma City-based Bank7, today announced the declaration of a quarterly cash dividend of $0.27 per share on its outstanding common stock. The dividend will be paid on July 7, 2026, to shareholders of record as of the close of business on June 19, 2026.

Bank7 Logo

About Bank7 Corp.

We are Bank7 Corp., a bank holding company headquartered in Oklahoma City, Oklahoma. Through our wholly-owned subsidiary, Bank7, we operate twelve full-service branches in Oklahoma, the Dallas/Fort Worth, Texas metropolitan area, and Kansas. We are focused on serving business owners and entrepreneurs by delivering fast, consistent, and well-designed loan and deposit products to meet their financing needs. We intend to grow organically by selectively opening additional branches in our target markets as well as pursuing strategic acquisitions.

Cautionary Statements Regarding Forward-Looking Information

This communication contains a number of forward-looking statements. These forward-looking statements reflect Bank7 Corp.’s current views with respect to, among other things, future events and Bank7 Corp.’s financial performance. Any statements about Bank7 Corp.’s expectations, beliefs, plans, predictions, forecasts, objectives, assumptions or future events or performance are not historical facts and may be forward-looking. These statements are often, but not always, made through the use of words or phrases such as “anticipate,” “believes,” “can,” “could,” “may,” “predicts,” “potential,” “should,” “will,” “estimate,” “plans,” “projects,” “continuing,” “ongoing,” “expects,” “intends” and similar words or phrases. Any or all of the forward-looking statements in (or conveyed orally regarding) this presentation may turn out to be inaccurate. The inclusion of or reference to forward-looking information in this presentation should not be regarded as a representation by Bank7 Corp. or any other person that the future plans, estimates or expectations contemplated by Bank7 Corp. will be achieved.

These forward-looking statements are subject to significant uncertainties because they are based upon: the amount and timing of future changes in interest rates, market behavior, and other economic conditions; future laws, regulations, and accounting principles; changes in regulatory standards and examination policies, and a variety of other matters. These other matters include, among other things, the direct and indirect effect of economic conditions on interest rates, credit quality, loan demand, liquidity, and monetary and supervisory policies of banking regulators. Bank7 Corp. has based these forward-looking statements largely on its current expectations and projections about future events and financial trends that Bank7 Corp. believes may affect its financial condition, results of operations, business strategy and financial needs. Bank7 Corp.’s actual results could differ materially from those anticipated in such forward-looking statements as a result of risks, uncertainties and assumptions that are difficult to predict. If one or more events related to these or other risks or uncertainties materialize, or if Bank7 Corp.’s underlying assumptions prove to be incorrect, actual results may differ materially from what Bank7 Corp. anticipates. You are cautioned not to place undue reliance on forward-looking statements. Further, any forward-looking statement speaks only as of the date on which it is made and Bank7 Corp. undertakes no obligation to update or revise any forward-looking statement to reflect events or circumstances after the date on which the statement is made or to reflect the occurrence of unanticipated events, except as may be required by law. All forward-looking statements herein are qualified by these cautionary statements.

Contact:

Thomas Travis
President & CEO
(405) 810-8600

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/bank7-corp-declares-quarterly-cash-dividend-on-common-stock-302789791.html

SOURCE Bank7 Corp.

eHealth and Nexben Partner to Expand ICHRA Opportunities for Health Benefit Brokers, Employers, and Employees

PR Newswire

Partnership to launch a new employee-centric ICHRA solution to help benefit brokers grow their business while supporting employer cost control and greater employee choice

INDIANAPOLIS and GRAND RAPIDS, Mich., June 4, 2026 /PRNewswire/ — eHealth (Nasdaq: EHTH), a leading private online health insurance marketplace, and Nexben, a leading health benefits administration platform, today announced a partnership to help employers offer more affordable, flexible health coverage options to their employees while equipping health benefit brokers with the tools to deliver and support Individual Coverage Health Reimbursement Arrangement (ICHRA) solutions.

The partnership is expected to introduce one of the market’s first employee-centric ICHRA solutions, combining eHealth’s nearly three decades of marketplace, enrollment, and advisory experience with Nexben’s ICHRA administration and payment technology. The eHealth/Nexben ICHRA solution aims to help employers manage the rising and unpredictable costs of traditional group health plans while enabling employees to confidently enroll in coverage from leading national and regional carriers.

“This partnership seeks to help make it easier for people to shop for health coverage with the same clarity and confidence they expect in other parts of their lives,” said Derrick Duke, CEO of eHealth. “Together with Nexben, our goal is to strengthen      what we deliver to employers and licensed insurance brokers, and make it easier for employees to compare plans, get quotes, enroll, and access support.”

Helping benefit brokers deliver ICHRA solutions

As ICHRA adoption grows, the partnership is designed to help brokers expand their role and better support employers and employees by offering brokers:

  • Smart quoting technology with data-driven estimates.
  • Integration with the leading insurers, ensuring seamless and accurate enrollments and making it easy for consumers to check coverage status.
  • Ability to maintain agent of record and preserve client relationships.
  • Licensing and advisory support in states where needed.
  • Employer and employee education, including trainings and onboarding support to help ensure a smooth transition.

Helping employees compare and choose coverage

With ICHRA, employers set a defined monthly contribution toward each employee’s coverage. Through the integrated platform, employees can: 

  • Compare hundreds of Affordable Care Act (ACA)-compliant plans from approximately 50 leading national and regional carriers.
  • See clear employer contributions alongside plan options.
  • Enroll online or by phone with support from licensed insurance agents.
  • Access medical, dental, and vision plans in one place.
  • Receive ongoing support throughout the year.

“Nexben’s partnership with eHealth was driven by a shared commitment to simplifying health benefits administration while also expanding employee choice,” said Mark Smith, CEO of Nexben. “By combining Nexben’s ICHRA administration and payment capabilities with eHealth’s marketplace and advisory expertise, we are focused on putting control back into the hands of consumers. We aim to achieve this by serving as the off-ramp for employers dealing with rising health insurance costs while giving employees what they want, not just what they need.”

Helping employers simplify administration and control costs

The combined solution is designed to enable employers to adopt ICHRA as a health benefit with greater ease and confidence by providing:

  • Average savings of 17% on healthcare costs.1
  • Flexibility to structure contributions across employee classes.
  • Real-time visibility into enrollments and participation.
  • Integrated enrollment and payment workflows.
  • Automated premium payments to reduce coverage gaps and service issues.

A more connected and scalable ICHRA solution

The partnership aims to deliver a unified and frictionless experience across quoting, enrollment, and payments, which is expected to reduce administrative complexity for employers while improving the experience for employees and benefit advisors.

This approach is also expected to provide employers with greater cost control and flexibility, contribute to higher employee satisfaction compared to traditional group plans,2 and enable licensed insurance brokers to maintain client relationships while expanding into ICHRA solutions.

The partnership is designed to support broader adoption of ICHRA, with enrollment in these plans increasing more than 50% year over year.3

About eHealth

For nearly 30 years, eHealth, Inc. (Nasdaq: EHTH) has helped millions of Americans find the healthcare coverage that fits their needs at a price they can afford, using data, artificial intelligence and a consumer-first approach to help people quickly and effectively compare insurance options. As a leading independent licensed insurance agency and advisor, eHealth offers access to plans from more than 180 health insurers, including national and regional companies, supporting consumers during their working years and retirement. eHealth’s team of licensed insurance agents helps match consumers with the insurance plans, services, and support they need to live healthier, more financially secure lives. For more information, visit eHealth or follow us on LinkedInFacebookInstagram, and X.  

eHealth media inquiries: [email protected]  

Investor relations contact:
Kate Sidorovich, CFA
Senior Vice President, Investor Relations & Corporate Development
[email protected] 

About Nexben

Nexben is an end-to-end benefits platform powering up defined contribution and ICHRA strategies. The organization’s turnkey enrollment and marketplace solution provides better administration, payments, and reconciliation, supporting the broker’s critical role throughout the entire consultative process. Nexben partners with brokers and advisors to develop innovative strategies that create substantial savings and high satisfaction rates for their clients. The company’s commitment to enhancing healthcare accessibility ensures that employees can confidently navigate their health options and gain more control over their healthcare decisions. For more information about Nexben, please visit nexben.com.

Media Contact:

[email protected]   

Forward-Looking Statements

This press release includes forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements in this press release include, but are not limited to, the following: statements regarding the expected benefits of the partnership between eHealth and Nexben; industry and market trends, including market opportunity, consumer demand and competitive advantages of the partnership; expectations regarding the adoption and growth of Individual Coverage Health Reimbursement Arrangements (ICHRAs); expectations regarding technological and digital capabilities of the combined platform; expected cost savings and administrative efficiencies for employers, and improved experiences and service capabilities for employees and benefit advisors; expectations regarding the functionality, performance and scalability of the combined platform; and other statements regarding future operations, financial condition, prospects and business strategies of eHealth and/or Nexben.

These forward-looking statements are inherently subject to various risks and uncertainties that could cause actual results to differ materially from the statements made. The risks and uncertainties that could cause actual results to differ materially from those expressed or implied by such forward-looking statements include, but are not limited to: changes in laws, regulations and guidelines, including those relating to healthcare reform, ICHRA or the Affordable Care Action; market adoption of ICHRA solutions; and the ability to integrate and deliver the combined solution and realize the anticipated benefits of the partnership, among others.

Other factors that could cause actual results to differ from those contained in the forward-looking statements are described in eHealth’s most recent Quarterly Report on Form 10-Q or Annual Report on Form 10-K filed with the Securities and Exchange Commission and available on the Investor Relations page of eHealth’s website at https://ir.ehealthinsurance.com and on the Securities and Exchange Commission’s website at www.sec.gov.

These forward-looking statements on current expectations about future events, and these statements are not guarantees of future performance. All forward-looking statements in this press release are based on information available to eHealth as of the date hereof, and eHealth does not assume any obligation to update the forward-looking statements provided to reflect events that occur or circumstances that exist after the date on which they were made, except as required by law.

1 Based on an eHealth analysis of third-party data on individual rates compared to traditional group plan rates in OH, MN, GA, KY, IN & FL.
2 Deft Research, 2026, https://deftresearch.com/commercial-group-ichra-and-alternative-health-plans-study/
3
HRA Council, 2025, https://www.hracouncil.org/report

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/ehealth-and-nexben-partner-to-expand-ichra-opportunities-for-health-benefit-brokers-employers-and-employees-302790948.html

SOURCE eHealth, Inc.

Goodnites® Partners with U.S Pro Soccer Captain Tim Ream to Help Destigmatize Childhood Bedwetting

PR Newswire

U.S. pro soccer captain and father shares his personal bedwetting experience to help normalize childhood nighttime accidents and empower the next generation to Never Stop Dreaming

CHICAGO, June 4, 2026 /PRNewswire/ — Tim Ream, U.S. pro soccer captain, has teamed up with Goodnites®, the #1 Nighttime Underwear1 brand to share, for the first time, his childhood experience with bedwetting. A respected leader on and off the field, Ream is also a dedicated father who is using his platform to help support families and children. Goodnites is joining forces with Ream to uplift children experiencing bedwetting with confidence, courage, and positivity, sending a powerful message that nighttime accidents are a normal part of childhood development rather than a barrier to your potential.

Why This Partnership Matters: One in Six Children Experience Bedwetting
Bedwetting is common, affecting approximately 1 in 6 children, ages 3–12, yet many children who experience it can feel isolated and ashamed. Ream experienced bedwetting until age 11, but it didn’t stop him from becoming a professional athlete competing at the highest level of international soccer.

“I’m partnering with Goodnites because I know firsthand that bedwetting doesn’t define you or your future,” said Tim Ream. “It was tough, but it taught me resilience. Today, as a father, I want to share my story to let children know they are not alone. Bedwetting is not a reflection of who they are and doesn’t have to keep them from going after their dreams.”

Campaign Details: “To My Younger Self” 
Ream is featured in the brand’s new multimedia campaign chronicling his journey from a child navigating bedwetting to a celebrated professional athlete and emphasizes that even though bedwetting feels overwhelming when you’re little, it does not define who you will become. Watch Ream speak to his younger self here: https://youtu.be/ZKsPcxo8Xl4.

“What Tim Ream says to his younger self matters because it’s real. He’s lived it, and now he’s using his platform to remind kids that bedwetting is common and that they can still be confident and pursue their dreams,” said Dan Jackson, North America Vice President & General Manager for Child Care.

Goodnites Brand Mission: Support Beyond the Product
Goodnites has always supported families navigating childhood bedwetting, and this partnership deepens our mission to support not just nighttime needs, but children’s confidence and dreams. Through this partnership, Goodnites, the brand that offers nighttime protection against bedwetting accidents, continues to support families navigating bedwetting with products and resources that promote confidence and emotional well-being.

Follow @goodnites on Instagram and Facebook, and @goodnitesbrand on TikTok to learn more.

1Youth Pant Category Share Data

About Goodnites
Goodnites, part of Kimberly–Clark, is the #1 Nighttime Underwear 1 brand founded in 1994 that is focused on helping children, teens and families navigate bedwetting. Beyond being a trusted brand that offers nighttime solutions, the Goodnites website provides educational resources, guidance for caregivers and community outreach aimed at reducing stigma and focuses on children’s well–being. Goodnites brand partners with expert organizations and is available nationwide through major retailers and online; more at http://goodnites.com/en-us.

About Kimberly-Clark
Kimberly-Clark (NASDAQ: KMB) and its trusted brands are an indispensable part of life for people in more than 175 countries and territories. Our portfolio of brands, including Huggies, Kleenex, Scott, Kotex, Cottonelle, Poise, Depend, Andrex, Pull-Ups, Goodnites, Intimus, Plenitud, Sweety, Softex, Viva and WypAll, hold No. 1 or No. 2 share positions in approximately 70 countries. Our company’s purpose is to deliver Better Care for a Better World. We are committed to using sustainable practices designed to support a healthy planet, build strong communities, and enable our business to thrive for decades to come. To keep up with the latest news and learn more about the company’s more than 150-year history of innovation, visit https://www.kimberly-clark.com/en-us/.

Media Contacts:
Kimberly-Clark Media Relations
[email protected]

HUNTER
[email protected]

 

Goodnites® Never Stop Dreaming

Goodnites

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/goodnites-partners-with-us-pro-soccer-captain-tim-ream-to-help-destigmatize-childhood-bedwetting-302791552.html

SOURCE Kimberly-Clark Corporation

IAC is Now People Incorporated with New Ticker Symbol

PR Newswire

Shares will begin trading under new Nasdaq stock symbol “PPLI” effective
at market open today

NEW YORK, June 4, 2026 /PRNewswire/ — Today People Incorporated, formerly IAC (Nasdaq: IAC), announced its legal name change and that the Company’s common stock, listed on the Nasdaq Capital Market, will begin trading under the new ticker symbol PPLI, effective at market open today June 4, 2026. People Incorporated is the public entity that owns America’s largest publisher People Inc., and a significant minority stake in MGM Resorts International.

People Incorporated

The planned name change was previously announced in a Letter to Shareholders on April 28, 2026.

The ticker change takes effect on June 4, 2026. No action is required by shareholders. The Company’s common stock will continue to trade on the Nasdaq and its CUSIP number will remain unchanged. Investors can visit ir.people-incorporated.com for further company information.


About People Incorporated
 

People Incorporated (Nasdaq: PPLI) is the owner of America’s largest publisher, People Inc., home to more than 40 celebrated brands including PEOPLE, Food & Wine, Travel + Leisure, InStyle, Better Homes & Gardens, and Southern Living, attracting a total of 175 million consumers each month. The company also holds a significant minority stake in MGM Resorts International, reflecting our belief in the power and potential of businesses built around enduring consumer brands and iconic, real-world experiences. 

People Incorporated represents the latest evolution in a long tradition of entrepreneurial ownership, disciplined capital allocation, and opportunistic value creation. Over three decades, the company has built, operated, invested in, and spun off many of the internet and media industry’s defining businesses, and that same spirit of opportunism drives us today. People Incorporated is headquartered in New York City. Visit ir.people-incorporated.com.


Contact Us

People Incorporated Investor Relations

Mark Schneider

(212) 314-7400

People Incorporated Corporate Communications 

Valerie Combs

(212) 314-7251

 

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/iac-is-now-people-incorporated-with-new-ticker-symbol-302791180.html

SOURCE People Incorporated

Aeroméxico May 2026 Traffic Results

MEXICO CITY, Mexico, June 04, 2026 (GLOBE NEWSWIRE) — Grupo Aeroméxico S.A.B. de C.V. (NYSE: AERO & BMV: AERO) (“Aeroméxico”) reports its May 2026 operational results:

  • Grupo Aeroméxico transported 2 million and 102 thousand passengers in May 2026, a 2.1% year-over-year increase. International passengers increased by 4.6%, while domestic passengers increased by 0.9%.
  • Aeroméxico’s total capacity, measured in available seat miles (ASMs), increased by 4.7% year-over-year. International ASMs increased by 7.0%, while domestic capacity decreased by 0.3% year-over-year.
  • Demand, measured in passenger miles (RPMs), increased by 5.2% year-over-year. International demand increased by 6.8%, while domestic demand increased by 1.6%, both figures compared to May 2025.
  • Aeroméxico’s May 2026 load factor was 85.8%, a 0.4 p.p. increase as compared to May 2025. International load factor decreased by 0.2 p.p., and domestic load factor increased by 1.6 p.p.

Andrés Conesa, Chief Executive Officer stated

:
May traffic performance underscored the strength of our network and commercial strategy. Demand remained strong and robust, outpacing capacity growth and supporting healthy load factors across the network. We closed the month on a high note, with the final week of May delivering the highest weekly sales in our Company’s history. Demand trends continue to track in line with the outlook provided in April. As we move to the second half of the year, we will continue to actively manage capacity and network deployment to capitalize on these strong demand opportunities and maximize profitability.”

   May     Cumulative to May 
  2026
2025
Var vs
2025
  2026
2025
Var vs
2025
               
Passengers (itinerary + charter, thousands)               
Domestic           1,407             1,394   0.9%              6,567              6,693   -1.9%
International              695                665   4.6%              3,388              3,331   1.7%
Total           2,102             2,059   2.1
%
             9,954            10,024   -0.7%
               
ASMs (itinerary + charter, millions)               
Domestic              925                927   -0.3%              4,425              4,510   -1.9%
International           2,226             2,081   7.0%            10,401            10,265   1.3%
Total           3,151             3,009   4.7
%
           14,826            14,776   0.3
%
               
RPMs (itinerary + charter, millions)               
Domestic              791                779   1.6%              3,704              3,776   -1.9%
International           1,914             1,792   6.8%              8,905              8,589   3.7%
Total           2,705             2,571   5.2
%
           12,609            12,365   2.0
%
               
Load Factor (itinerary, %)      p.p.       p.p.
Domestic 85.6 % 84.0 % 1.6   83.7 % 83.7 % -0.0
International 86.0 % 86.1 % -0.2   85.6 % 83.7 % 1.9
Total 85.8 % 85.5 % 0.4   85.1 % 83.7 % 1.4
                       

Figures may not sum to total due to rounding.

The information included within this report has not been audited and does not provide information on the Company’s future performance. Aeromexico’s future performance depends on many factors and it cannot be inferred that any period’s performance or its year-over-year comparison will be an indicator of similar future performance.

Glossary:

  • “RPMs” Revenue Passenger Miles represent one revenue-passenger transported one mile. This includes itinerary and charter flights. The total RPMs equals the number of revenue-passengers transported multiplied by the total distance flown.

  • “ASMs” Available Seat Miles represent the number of available seats multiplied by the distance flown. This metric is an indicator of the airline’s capacity. It equals one seat offered for one mile, whether the seat is used.

  • “Load Factor” equals the number of passengers transported as a percentage of the number of seats offered. It is a measure of the airline’s capacity utilization. This metric considers the total passengers transported and total seats available in itinerary flights only.

  • “Passengers” refers to the total number of passengers transported by the airline.

This press release contains certain forward-looking statements that reflect the current views and/or expectations of the Company and its management with respect to its performance, business and future events. We use words such as “believe,” “anticipate,” “plan,” “expect,”, “intend,” “target,” “estimate,” “project,” “predict,” “forecast,” “guideline,” “should” and other similar expressions to identify forward-looking statements, but they are not the only way we identify such statements. Such statements are subject to a number of risks, uncertainties and assumptions. We caution you that a number of important factors could cause actual results to differ materially from the plans, objectives, expectations, estimates and intentions expressed in this release. The Company is under no obligation and expressly disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.


About Grupo Aeroméxico


Grupo Aeroméxico, S.A.B. de C.V., is a holding company whose subsidiaries are engaged in commercial aviation in Mexico and in the promotion of passenger loyalty programs. Aeroméxico, Mexico’s global airline, operates primarily out of Terminal 2 of the Mexico City International Airport. Its destination network extends across Mexico, the United States, Canada, Central America, South America, Asia, and Europe. Aeroméxico’s current operating fleet includes Boeing 787 and 737 aircraft, as well as Embraer 190. Aeroméxico is a founding member of SkyTeam, an alliance celebrating 25 years and offering connectivity across more than 145 countries through its 18 partner airlines.

www.aeromexico.com

www.skyteam.com

Contact information: 
[email protected] 



CN Reports New Monthly Record for Propane Shipments to Watson Island

MONTREAL, June 04, 2026 (GLOBE NEWSWIRE) — CN (TSX: CNR) (NYSE: CNI) announced today that propane export shipments from South Beamer, Alberta to Watson Island, British Columbia reached an all-time monthly record for the corridor in May, while staying within the existing commercial arrangements.

The achievement represents an increase in carloads of 40% compared to May 2025 and beating CN’s previous monthly record from August 2024, reflecting continued operational improvements across the supply chain. CN’s record-setting performance was supported by train length optimizations, enhanced network efficiency, and strong execution across the corridor, enabling greater volumes of product to move reliably to the West Coast.

CN’s focus on service consistency and asset utilization continues to create additional capacity, to support customer growth opportunities. As demand for Canadian propane exports remains strong, CN remains committed to working closely with Pembina and supply chain partners to provide safe, efficient, and reliable transportation solutions.

About CN

CN powers the economy by safely transporting more than 300 million tons of natural resources, manufactured products, and finished goods throughout North America every year for its customers. With its nearly 20,000-mile rail network and related transportation services, CN connects Canada’s Eastern and Western coasts with the U.S. Midwest and the U.S. Gulf Coast, contributing to sustainable trade and the prosperity of the communities in which it operates since 1919.



Contacts:



Media



Investment Community

Ashley Michnowski Jamie Lockwood
Senior Manager Vice-President
Media Relations Investor Relations & Special Projects
(438) 596-4329 (514) 399-0052
[email protected] [email protected]



Scilex Holding Company (“Scilex”) Announces a Payment Date of June 15, 2026 for the Previously Announced Dividend of Semnur Pharmaceuticals, Inc. Common Stock to Holders of Scilex Common Stock and other Eligible Equity Securities

PALO ALTO, Calif., June 04, 2026 (GLOBE NEWSWIRE) — Scilex Holding Company (“Scilex” or the “Company”) (Nasdaq: SCLX), an innovative revenue-generating company focused on acquiring, developing, and commercializing non-opioid pain management products for the treatment of acute and chronic pain and neurodegenerative and cardiometabolic disease, today announced that its board of directors (the “Board”) has set June 15, 2026 as the payment date (the “Payment Date”) for the previously announced dividend of Semnur Pharmaceuticals, Inc. (“Semnur”) (OTC: SMNR) common stock held by the Company to its stockholders and certain other eligible holders of Scilex securities (collectively, the “Participating Holders”) that held such securities as of the record date for the dividend, which is June 1, 2026 (the “Record Date”). Nasdaq will determine the ex-dividend date in accordance with their rules.

The Participating Holders will be entitled to receive one (1) share of common stock of Semnur for each share of Scilex common stock held (or for each share of common stock issuable or deemed issuable upon exercise or conversion of such other eligible securities, in each case pursuant to the contractual rights of such other securities). Scilex currently beneficially owns approximately 186 million shares of Semnur common stock and plans to distribute approximately 14.0 million of such shares to the Participating Holders on the foregoing basis.

The Record Date and the Payment Date for the dividend may be changed by the Board for any reason at any time prior to the actual Payment Date, and payment of the dividend is conditioned upon the Board having not revoked the dividend prior to the Payment Date, including for a material change to the solvency or surplus analysis presented to the Board.

For more information on Scilex Holding Company, refer to www.scilexholding.com

For more information on Semnur Pharmaceuticals, Inc., refer to www.semnurpharma.com

For more information on ZTlido® including Full Prescribing Information, refer to www.ztlido.com.

For more information on ELYXYB®, including Full Prescribing Information, refer to www.elyxyb.com.

For more information on Gloperba®, including Full Prescribing Information, refer to www.gloperba.com.

https://www.facebook.com/scilex.pharm

https://www.linkedin.com/company/scilex-holding-company/

[email protected]

About Scilex Holding Company

Scilex is an innovative revenue-generating company focused on acquiring, developing and commercializing non-opioid pain management products for the treatment of acute and chronic pain and neurodegenerative and cardiometabolic disease. Scilex targets indications with high unmet needs and large market opportunities with non-opioid therapies for the treatment of patients with acute and chronic pain and is dedicated to advancing and improving patient outcomes. Scilex’s commercial products include: (i) ZTlido® (lidocaine topical system) 1.8%, a prescription lidocaine topical product approved by the U.S. Food and Drug Administration (the “FDA”) for the relief of neuropathic pain associated with postherpetic neuralgia, which is a form of post-shingles nerve pain; (ii) ELYXYB®, a potential first-line treatment and the only FDA-approved, ready-to-use oral solution for the acute treatment of migraine, with or without aura, in adults; and (iii) Gloperba®, the first and only liquid oral version of the anti-gout medicine colchicine indicated for the prophylaxis of painful gout flares in adults.

In addition, Scilex has three product candidates: (i) SP-102 (10 mg, dexamethasone sodium phosphate viscous gel) (“SEMDEXA” or “SP-102”), which is owned by Semnur (a majority owned subsidiary of Scilex) and is a novel, viscous gel formulation of a widely used corticosteroid for epidural injections to treat lumbosacral radicular pain, or sciatica, for which Scilex has completed a Phase 3 study and was granted Fast Track status from the FDA in 2017; (ii) SP-103 (lidocaine topical system) 5.4%, (“SP-103”), a next-generation, triple-strength formulation of ZTlido, for the treatment of acute pain and for which Scilex has recently completed a Phase 2 trial in acute low back pain. SP-103 has been granted Fast Track status from the FDA in low back pain; and (iii) SP-104 (4.5 mg, low-dose naltrexone hydrochloride delayed-release capsules) (“SP-104”), a novel low-dose delayed-release naltrexone hydrochloride being developed for the treatment of fibromyalgia.

Scilex is headquartered in Palo Alto, California.

About Semnur Pharmaceuticals, Inc.

Semnur is a clinical late-stage specialty pharmaceutical company focused on the development and commercialization of novel non-opioid pain therapies. Semnur’s product candidate, SP-102 (SEMDEXA™), is the first non-opioid novel gel formulation administered epidurally in development for patients with moderate to severe chronic radicular pain/sciatica.

Semnur is headquartered in Palo Alto, California

Forward-Looking Statements

This press release includes forward-looking statements that involve risks and uncertainties. Forward-looking statements are statements that are not historical facts and may be accompanied by words that convey projected future events or outcomes, such as “believe,” “may,” “will,” “estimate,” “continue,” “anticipate,” “intend,” “expect,” “should,” “would,” “plan,” “predict,” “potential,” “seem,” “seek,” “future,” “outlook” or variations of such words or by expressions of similar meaning. These forward-looking statements include, but are not limited to, statements regarding future events, including Scilex’s dividend of Semnur common stock and the timing thereof (including that the Board may change the Record Date and, as a result, the Payment Date). These statements are based on management’s current expectations and are not predictions of actual performance. These forward-looking statements are provided for illustrative purposes only and are not intended to serve as, and must not be relied on, by any investor as a guarantee, an assurance, a prediction or a definitive statement of fact or probability. Actual events and circumstances are difficult or impossible to predict and will differ from assumptions. Many actual events and circumstances are beyond the control of Scilex. These statements are subject to a number of risks and uncertainties regarding Scilex’s business. These risks and uncertainties include, but are not limited to, risks related to legal proceedings that may be instituted against Scilex regarding the dividend of Semnur common stock and the payment thereof to the Participating Holders; risks associated with the right of the Board to change the Record Date and the Payment Date and/or revoke the dividend; general economic, political and business conditions; the ability of Scilex and its subsidiaries to develop and successfully market products; the ability of Scilex and its subsidiaries to grow and manage growth profitably and retain its key employees; the risk that the potential product candidates that Scilex develops may not progress through clinical development or receive required regulatory approvals within expected timelines or at all; risks relating to uncertainty regarding the regulatory pathway for Scilex’s product candidates; the risk that Scilex’s product candidates may not be beneficial to patients or successfully commercialized; the risk that Scilex has overestimated the size of the target patient population, their willingness to try new therapies and the willingness of physicians to prescribe these therapies; risks that the prior results of the clinical trials may not be replicated; regulatory and intellectual property risks; and other risks and uncertainties indicated from time to time and other risks set forth in Scilex’s filings with the SEC. There may be additional risks that Scilex presently does not know or that Scilex currently believes are immaterial that could also cause actual results to differ from those contained in the forward-looking statements. In addition, forward-looking statements provide Scilex’s expectations, plans or forecasts of future events and views as of the date of the communication. Scilex anticipates that subsequent events and developments will cause such assessments to change. However, while Scilex may elect to update these forward-looking statements at some point in the future, Scilex specifically disclaims any obligation to do so. These forward-looking statements should not be relied upon as representing Scilex’s assessments as of any date subsequent to the date of this communication. Accordingly, investors are cautioned not to place undue reliance on these forward-looking statements.

Contacts:

Investors and Media
Scilex Holding Company
960 San Antonio Road
Palo Alto, CA 94303
Office: (650) 516-4310

Email: [email protected]

Website: www.scilexholding.com

SEMDEXA™ (SP-102) is a trademark owned by Semnur Pharmaceuticals, Inc., a majority-owned subsidiary of Scilex Holding Company. A proprietary name review by the FDA is planned.

ZTlido® is a registered trademark owned by Scilex Pharmaceuticals Inc., a wholly-owned subsidiary of Scilex Holding Company.

Gloperba® is the subject of an exclusive, transferable license to use the registered trademark by Scilex Holding Company.

ELYXYB® is a registered trademark owned by Scilex Holding Company.

Scilex Bio™ is a trademark owned by Scilex Holding Company.

All other trademarks are the property of their respective owners.

© 2026 Scilex Holding Company All Rights Reserved.



EpicQuest Education to Present at the Emerging Growth Conference

The Live Webcast is Scheduled for June 11, 2026 at 9:00 am ET

TOLEDO, Ohio, June 04, 2026 (GLOBE NEWSWIRE) — EpicQuest Education Group International Limited (Nasdaq: EEIQ), (“EpicQuest Education”, “EEIQ” or the “Company”), a provider of higher education for domestic and international students in the US, Canada and the UK, announced today that it will be presenting via video webcast at the Emerging Growth Conference.

Zhenyu Wu, Chief Financial Officer, and Craig Wilson, independent Board Member, will be presenting on behalf of the Company. EpicQuest Education is scheduled to present via video webcast on Thursday, June 11, 2026 at 9:00 AM. To register for the online, live event, please click on the following link:

https://goto.webcasts.com/starthere.jsp?ei=1757504&tp_key=cc5c9b4321&sti=eeiq

There will be a live question and answer session following the presentation, and attendees can also submit their questions in advance to [email protected]. If attendees are not able to join the event live on the day of the conference, an archived webcast will be made available on EmergingGrowth.com and on the Emerging Growth YouTube Channel at http://www.YouTube.com/EmergingGrowthConference.

About the Emerging Growth Conference

The Emerging Growth Conference provides public companies a robust platform to present and communicate to the investment community in a time effective manner. The Conference focus and coverage includes companies in a wide range of growth sectors, and its audience includes potentially tens of thousands of individual and institutional investors, as well as investment advisors and analysts. Conference presentations will be conducted through video webcasts and will take place in the Eastern Time Zone.

About EpicQuest Education Group International Limited

EpicQuest Education Group International Limited (“EpicQuest Education” or the “Company”) provides comprehensive education solutions for domestic and international students seeking university and University degrees in the US, Canada and the UK. The Company owns and operates Davis Academy a/k/a EduGlobal College, based in British Columbia, Canada, which focuses on English proficiency educational programming for students pursuing academic degrees. The Company operates and is a 70% owner of Davis University, a career training university located in Toledo, Ohio. In addition, the Company has a recruiting relationship with the Miami University Regional campuses, where it maintains residential facilities, a full-service cafeteria, recreational facilities, shuttle buses and an office for the regional campuses that provides study abroad and post-study services for its students; these facilities are not owned, maintained, operated or are a part of Miami University. The Company is also a recruiting agent for the University of the West of Scotland (through The Education Group (London) Ltd) and Coventry University, both of which are located in the UK. For more information, please visit www.epicquesteducation.com/.

Safe Harbor Statement

Certain of the statements made in this press release are “forward-looking statements” within the meaning and protections of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Forward-looking statements include statements with respect to our beliefs, plans, objectives, goals, expectations, anticipations, assumptions, estimates, intentions, and future performance, and involve known and unknown risks, uncertainties and other factors, which may be beyond our control, and which may cause the actual results, performance, capital, ownership or achievements of the Company to be materially different from future results, performance or achievements expressed or implied by such forward-looking statements. All statements other than statements of historical fact are statements that could be forward-looking statements. You can identify these forward-looking statements through our use of words such as “may,” “will,” “anticipate,” “assume,” “should,” “indicate,” “would,” “believe,” “contemplate,” “expect,” “estimate,” “continue,” “plan,” “point to,” “project,” “could,” “intend,” “target” and other similar words and expressions of the future.

All written or oral forward-looking statements attributable to us are expressly qualified in their entirety by this cautionary notice, including, without limitation, those risks and uncertainties described in our most recent Form 20-F and otherwise in our SEC reports and filings. Such reports are available upon request from the Company, or from the Securities and Exchange Commission, including through the SEC’s Internet website at http://www.sec.gov. We have no obligation and do not undertake to update, revise or correct any of the forward-looking statements after the date hereof, or after the respective dates on which any such statements otherwise are made.

Source: EpicQuest Education Group International Limited



Contacts:

EpicQuest Education Group International Limited
+1 513-649-8350
[email protected]

Investor Relations:

Precept Investor Relations LLC
David Rudnick        
+1 646-694-8538
[email protected]